Breast Cancer

Showing NaN - NaN of 420

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Active, not recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +20 more
  • Actigraph
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 4, 2022

Breast Cancer Trial in Worldwide (Abemaciclib, Anastrozole, Letrozole)

Active, not recruiting
  • Breast Cancer
  • Chandler, Arizona
  • +166 more
Jul 21, 2022

Breast Cancer Trial in Worldwide (Elacestrant, Standard of Care)

Active, not recruiting
  • Breast Cancer
  • Tucson, Arizona
  • +167 more
Jul 19, 2022

Advanced Malignant Tumor, Breast Cancer, Ovarian Cancer Trial in United States (AMXI-5001:Dose Escalation Phase I,

Recruiting
  • Advanced Malignant Neoplasm
  • +5 more
  • AMXI-5001:Dose Escalation Phase I
  • AMXI-5001:Dose Expansion Phase II
  • Phoenix, Arizona
  • +7 more
Jul 18, 2022

Breast Cancer Trial in United States (Letrozole, Tamoxifen, Palbociclib)

Active, not recruiting
  • Breast Cancer
  • Stamford, Connecticut
  • +10 more
Jul 15, 2022

Sentinel Lymph Node Biopsy, Breast Cancer, Melanoma Trial in Orange, Houston (pudexacianinium chloride)

Recruiting
  • Sentinel Lymph Node Biopsy
  • +2 more
  • pudexacianinium chloride
  • Orange, California
  • +1 more
Jul 11, 2022

Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

Recruiting
  • Ovarian Cancer
  • +12 more
  • San Francisco, California
  • +44 more
Jul 12, 2022

Breast Cancer, HER2-positive Trial in Houston (Zanidatamab, Letrozole, Tamoxifen)

Recruiting
  • Breast Cancer
  • HER2-positive
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022

Breast Cancer Trial in Worldwide (Ribociclib, Letrozole, Goserelin)

Active, not recruiting
  • Breast Cancer
  • Anchorage, Alaska
  • +495 more
Jun 15, 2022

Contralateral Prophylactic Mastectomy (CPM)

Completed
  • Breast Cancer
  • Questionnaires
  • Houston, Texas
  • +1 more
Jun 29, 2022

Breast Cancer, Solid Tumors Trial in Boston, Grand Rapids, Houston (PF-07220060 + PF-07104091 combination dose escalation,

Recruiting
  • Breast Cancer
  • Solid Tumors
  • PF-07220060 + PF-07104091 combination dose escalation
  • +2 more
  • Grand Rapids, Michigan
  • +1 more
Jun 28, 2022

Breast Cancer Trial in New York, Pittsburgh, Houston (Stereotactic Body Radiation Therapy (SBRT) (50GY in 5 fractions),

Recruiting
  • Breast Cancer
  • Stereotactic Body Radiation Therapy (SBRT) (50GY in 5 fractions)
  • +2 more
  • New York, New York
  • +4 more
Jun 29, 2022

Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,

Active, not recruiting
  • Breast Cancer
  • +10 more
  • Los Angeles, California
  • +7 more
Jun 21, 2022

Tumors, Ovarian Cancer, Breast Cancer Trial in Houston (ZN-c3, Bevacizumab, Pembrolizumab)

Not yet recruiting
  • Tumors
  • +4 more
  • Houston, Texas
    MD Anderson Cancer Center
Jun 20, 2022

Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in United States (NGM831, NGM831 plus pembrolizumab)

Recruiting
  • Pancreatic Cancer
  • +15 more
  • Gilbert, Arizona
  • +4 more
Jun 21, 2022

Breast Cancer Trial in United States (therapeutic conventional surgery, whole breast irradiation)

Active, not recruiting
  • Breast Cancer
  • therapeutic conventional surgery
  • whole breast irradiation
  • Hot Springs, Arkansas
  • +349 more
Jun 16, 2022

Breast Cancer Trial in United States (Lapatinib, Letrozole, Trastuzumab)

Active, not recruiting
  • Breast Cancer
  • Birmingham, Alabama
  • +7 more
May 15, 2022

Breast Cancer Trial in Houston (TAA-specific CTLs)

Active, not recruiting
  • Breast Cancer
  • TAA-specific CTLs
  • Houston, Texas
  • +1 more
May 20, 2022

Breast Cancer Trial in Worldwide (Enzalutamide, exemestane, Placebo (for enzalutamide))

Active, not recruiting
  • Breast Cancer
  • Aurora, Colorado
  • +132 more
Apr 26, 2022

Breast Cancer, Breast Tumor, Breast Cancer Female Trial in Houston (Paclitaxel, Carboplatin, Trastuzumab)

Not yet recruiting
  • Breast Cancer
  • +10 more
  • Houston, Texas
  • +1 more
May 15, 2022

Breast Cancer, Gastrointestinal Cancer, Hematologic Cancer Trial in Houston (OPTIMISE)

Recruiting
  • Breast Cancer
  • +2 more
  • OPTIMISE
  • Houston, Texas
    Baylor College of Medicine
May 16, 2022

Solid Tumor, Adult, Epithelial Ovarian Cancer, Small Cell Lung Carcinoma Trial in United States (CBX-12)

Recruiting
  • Solid Tumor, Adult
  • +11 more
  • New Haven, Connecticut
  • +3 more
May 9, 2022

Breast Cancer Trial in Worldwide (Amcenestrant-matching , SAR439859, Palbociclib)

Active, not recruiting
  • Breast Cancer
  • Amcenestrant-matching placebo
  • +5 more
  • Daphne, Alabama
  • +299 more
May 5, 2022